| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 13.016 | 14.793 | 19.470 | 18.881 | 21.226 | 27.327 |
| Total Income - EUR | - | - | - | - | 13.016 | 15.367 | 19.480 | 18.881 | 21.226 | 27.327 |
| Total Expenses - EUR | - | - | - | - | 37.246 | 22.066 | 19.007 | 17.772 | 19.310 | 22.063 |
| Gross Profit/Loss - EUR | - | - | - | - | -24.230 | -6.699 | 473 | 1.108 | 1.916 | 5.265 |
| Net Profit/Loss - EUR | - | - | - | - | -24.363 | -6.933 | 284 | 540 | 1.619 | 4.423 |
| Employees | - | - | - | - | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Sanus Lalimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 536 | 31.580 | 26.746 | 22.855 | 19.353 | 16.215 |
| Current Assets | - | - | - | - | 3.553 | 3.848 | 3.316 | 1.789 | 883 | 9.065 |
| Inventories | - | - | - | - | 3.390 | 2.433 | 2.379 | 376 | 0 | 0 |
| Receivables | - | - | - | - | 135 | 463 | 493 | 495 | 0 | 0 |
| Cash | - | - | - | - | 28 | 952 | 444 | 918 | 883 | 9.065 |
| Shareholders Funds | - | - | - | - | -24.320 | -30.790 | -29.823 | -29.375 | -27.667 | -23.090 |
| Social Capital | - | - | - | - | 42 | 43 | 42 | 43 | 42 | 42 |
| Debts | - | - | - | - | 28.409 | 66.218 | 60.997 | 56.128 | 49.015 | 49.475 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Sanus Lalimed S.r.l.